We believe that in vitro expanded autologous/heterologous Tregs may help treat autoimmune diseases, including SLE, and that CD4+CD25low/-GITR+ cells are interesting from this point of view, because they appear to be a homeostatic attempt to counteract the disease. Here, TNFRSF18 is linked to systemic lupus erythematosus.